DE69230349T2 - Cyclopropanderivat - Google Patents

Cyclopropanderivat

Info

Publication number
DE69230349T2
DE69230349T2 DE69230349T DE69230349T DE69230349T2 DE 69230349 T2 DE69230349 T2 DE 69230349T2 DE 69230349 T DE69230349 T DE 69230349T DE 69230349 T DE69230349 T DE 69230349T DE 69230349 T2 DE69230349 T2 DE 69230349T2
Authority
DE
Germany
Prior art keywords
cyclopropane derivative
independently
cyclopropane
derivative
purine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69230349T
Other languages
English (en)
Other versions
DE69230349D1 (de
Inventor
Satoshi Hatsuya
Takaaki Sekiyama
Takashi Tsuji
Satoshi Iwayama
Masahiko Okunishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of DE69230349D1 publication Critical patent/DE69230349D1/de
Application granted granted Critical
Publication of DE69230349T2 publication Critical patent/DE69230349T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DE69230349T 1991-03-05 1992-03-03 Cyclopropanderivat Expired - Lifetime DE69230349T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12323991 1991-03-05
JP18470991 1991-07-24

Publications (2)

Publication Number Publication Date
DE69230349D1 DE69230349D1 (de) 2000-01-05
DE69230349T2 true DE69230349T2 (de) 2000-07-27

Family

ID=26460224

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230349T Expired - Lifetime DE69230349T2 (de) 1991-03-05 1992-03-03 Cyclopropanderivat

Country Status (9)

Country Link
US (2) US5342840A (de)
EP (1) EP0502690B1 (de)
JP (1) JP2923933B2 (de)
KR (1) KR100232619B1 (de)
AT (1) ATE187173T1 (de)
CA (1) CA2062299C (de)
DE (1) DE69230349T2 (de)
DK (1) DK0502690T3 (de)
ES (1) ES2139588T3 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005053153A1 (de) * 2005-11-04 2007-05-16 Helmut Ristl Ristl-Getriebe

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950011530A (ko) * 1993-10-21 1995-05-15 도바 다다스 사이클로프로판 유도체 및 이를 함유하는 항바이러스제
TW282470B (de) * 1993-11-18 1996-08-01 Ajinomoto Kk
JP3769737B2 (ja) * 1994-03-30 2006-04-26 味の素株式会社 シクロプロパン誘導体及びその製造法
EP0845454A1 (de) * 1996-12-02 1998-06-03 Ajinomoto Co., Inc. Verfahren zur Herstellung von optisch aktiver Cyclopropan-Derivaten
JPH1129572A (ja) * 1997-07-10 1999-02-02 Ajinomoto Co Inc 核酸誘導体の精製法
JPH11255768A (ja) * 1998-03-09 1999-09-21 Ajinomoto Co Inc 抗ウイルス剤の製造方法
MY141789A (en) * 2001-01-19 2010-06-30 Lg Chem Investment Ltd Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
AU2002343604C1 (en) 2001-10-30 2009-09-17 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
JP2004026695A (ja) * 2002-06-24 2004-01-29 M's Science Corp 水性点眼用製剤
WO2005028434A2 (en) 2003-09-18 2005-03-31 Conforma Therapeutics Corporation Novel heterocyclic compounds as hsp90-inhibitors
FR2864901B1 (fr) * 2004-01-09 2007-10-05 Philippe Perovitch Composition pour le traitement au contact des hyposialies, incluant de la pilocarpine et a effets multiples
US7544672B2 (en) * 2005-03-30 2009-06-09 Conforma Therapeutics Corporation Alkynyl pyrrolo[2,3-d]pyrimidines and related analogs as HSP90-inhibitors
GB0814065D0 (en) * 2008-08-01 2008-09-10 Univ Leuven Kath Use of nucleoside analogs as anti-koi herpes virus molecules
WO2013059215A1 (en) 2011-10-17 2013-04-25 Biotheryx, Inc. Substituted biaryl alkyl amides
JP6051225B2 (ja) 2011-11-10 2016-12-27 アラタナ セラピューティクス エン ヴェー シクロプロパン誘導体の調製方法
JP5933033B2 (ja) 2012-01-20 2016-06-08 アラタナ セラピューティクス エン ヴェー 点眼剤組成物
CN104447749B (zh) * 2014-11-21 2016-06-01 河南师范大学 一种通过嘌呤对乙烯基环丙烷的选择性开环构建非环核苷的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016267A (en) * 1974-06-19 1977-04-05 Hoffmann-La Roche Inc. Sulfacytosine derivatives
US3923792A (en) * 1974-06-19 1975-12-02 Hoffmann La Roche Sulfacytosine derivatives
US4085273A (en) * 1975-06-12 1978-04-18 The Procter & Gamble Company Preparation of chrysanthemic acid compounds
CA1150299A (en) * 1978-08-17 1983-07-19 Pieter A. Verbrugge Intermediates in the preparation of cyclopropane-carboxylate esters and process for their manufacture
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
US4617304A (en) * 1984-04-10 1986-10-14 Merck & Co., Inc. Purine derivatives
US4859680A (en) * 1984-04-10 1989-08-22 Merck & Co., Inc. Pyrimidine derivatives as antiviral compounds
US4714777A (en) * 1984-06-21 1987-12-22 University Of Pittsburgh Cyclopropanone hydrate derivatives
US4782062A (en) * 1987-05-11 1988-11-01 Merck & Co., Inc. 9-(2-hydroxymethyl)cycloalkylmethyl) guanines
DE3869299D1 (de) * 1987-09-24 1992-04-23 Mitsubishi Chem Ind Verfahren zur herstellung eines cycloalkanols.
US5126345A (en) * 1988-03-30 1992-06-30 E. R. Squibb & Sons, Inc. Bis (hydroxymethyl) cyclobutyl triazolopyrimidines
US5208388A (en) * 1988-07-19 1993-05-04 Bayer Aktiengesellschaft 2,2-difluorocyclopropyl derivatives
DE3824432A1 (de) * 1988-07-19 1990-03-22 Bayer Ag 2,2-difluorcyclopropyl-derivate
US4918075A (en) * 1988-12-20 1990-04-17 E. R. Squibb & Sons, Inc. Purinyl and pyrimidinyl cyclobutanes and their use as antiviral agents
US4988703A (en) * 1989-05-22 1991-01-29 Abbott Laboratories Carbocyclic nucleoside analogs with antiviral activity
US5064961A (en) * 1989-12-18 1991-11-12 E. R. Squibb & Sons, Inc. Process for preparing an optically active cyclobutane nucleoside
US5095136A (en) * 1990-08-27 1992-03-10 E. R. Squibb & Sons, Inc. Method for preparing isoprenoid cyclopropane 1,1-dicarboxylates and derivatives thereof and novel intermediates
DE4222497A1 (de) * 1992-07-09 1994-01-13 Huels Chemische Werke Ag Verfahren zur Herstellung von chlorfreiem Cyclopropancarbonsäuremethylester

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005053153A1 (de) * 2005-11-04 2007-05-16 Helmut Ristl Ristl-Getriebe
DE102005053153B4 (de) * 2005-11-04 2007-07-19 Helmut Ristl Ristl-Getriebe

Also Published As

Publication number Publication date
US5449840A (en) 1995-09-12
JPH0578357A (ja) 1993-03-30
DK0502690T3 (da) 2000-05-22
KR920018052A (ko) 1992-10-21
EP0502690A3 (en) 1992-12-09
CA2062299C (en) 1999-05-25
KR100232619B1 (ko) 1999-12-01
DE69230349D1 (de) 2000-01-05
EP0502690A2 (de) 1992-09-09
ATE187173T1 (de) 1999-12-15
US5342840A (en) 1994-08-30
ES2139588T3 (es) 2000-02-16
CA2062299A1 (en) 1992-09-06
JP2923933B2 (ja) 1999-07-26
EP0502690B1 (de) 1999-12-01

Similar Documents

Publication Publication Date Title
ATE187173T1 (de) Cyclopropanderivat
NL300241I1 (nl) Hydroxymethyl(methyleencyclopentyl)uurines en -pyrimidines.
DK0471236T3 (da) Imidazopyridinderivater og deres anvendelse
DE69031057T2 (de) Nucleosidanaloge
FR2678930B1 (fr) Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
DE3851179T2 (de) Oxetanocin.
DK0429627T3 (da) Derivater af quinolin-3-carboxanilider
ES2093270T3 (es) Inhibidores de acat amido-tetrazolicos.
NO911322D0 (no) Nukleosid-derivater.
KR960702307A (ko) 항불안약 (anxiolytic agent)
GR3004905T3 (de)
SE9002445D0 (sv) Nytt cyklobutanderivat och foerfarande foer framstaellning av detsamma
ITMI912104A1 (it) Poliglucosidi da idrossialchilsorbitolo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition